Therapeutic impact of 18F-PSMA-1007 PET/MRI in staging intermediate/high-risk prostate cancer patients: Imaging biomarkers and radiomic analysis associated with tumor aggressiveness
Therapeutic impact of 18F-PSMA-1007 PET/MRI in staging intermediate/high-risk prostate cancer patients: Imaging biomarkers and radiomic analysis associated with tumor aggressiveness. // Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). – URL: https://www.sciencedirect.com/science/article/pii/S2253808926000376?dgcid=rss_sd_all
Therapeutic impact of 18F-PSMA-1007 PET/MRI in staging intermediate/high-risk prostate cancer patients: Imaging biomarkers and radiomic analysis associated with tumor aggressiveness. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). https://www.sciencedirect.com/science/article/pii/S2253808926000376?dgcid=rss_sd_all
“Therapeutic impact of 18F-PSMA-1007 PET/MRI in staging intermediate/high-risk prostate cancer patients: Imaging biomarkers and radiomic analysis associated with tumor aggressiveness.” Revista Española de Medicina Nuclear e Imagen Molecular (English Edition).
@article{article65196,
title = {Therapeutic impact of 18F-PSMA-1007 PET/MRI in staging intermediate/high-risk prostate cancer patients: Imaging biomarkers and radiomic analysis associated with tumor aggressiveness},
journal = {Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)},
url = {https://www.sciencedirect.com/science/article/pii/S2253808926000376?dgcid=rss_sd_all}
}